This announcement is a separate document:
双鹭药业：北京双鹭药业股份有限公司关于公司第二大股东可交债换股及减持导致持股比例变动超过5%的提示性公告
Shuanglu Pharmaceutical: An indicative announcement by Beijing Shuanglu Pharmaceutical Co., Ltd. on the change in shareholding ratio of more than 5% due to the redeemable debt exchange and reduction of holdings by the second largest shareholder of the comp
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.